egfr inhibitors - Robuta Search

https://www.mdpi.com/2077-0383/10/15/3219

The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in...

Colorectal cancer (CRC) is an important public health issue, in terms of incidence and mortality, with approximately 1.8 million new cases reported worldwide...

long term antibiotic therapy impact cutaneous adverse

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1396605/full

Frontiers | Marine-derived EGFR inhibitors: novel compounds targeting breast cancer growth and drug...

Breast cancer (BC) continues to be a major health challenge globally, ranking as the fifth leading cause of cancer mortality among women, despite advancement...

egfr inhibitors breast cancer frontiers marine derived

https://scirp.org/journal/paperinformation?paperid=62231

In Silico Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors

Discover how in silico pharmacokinetics studies analyze quinazoline candidates for EGFR inhibitors in the search for potential cancer drugs. Explore the...

egfr inhibitors silico pharmacokinetics studies quinazolines

https://www.muni.cz/en/research/publications/1706256

Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors...

epidermal growth factor egfr gene mutation testing receptor prior

https://pubmed.ncbi.nlm.nih.gov/31023512/

Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors

lead generation exon

https://www.brighamhealthonamission.org/2024/03/26/patients-with-egfr-mutant-nsclc-may-benefit-from-targeted-therapy-more-than-checkpoint-inhibitors/?share=print

Patients With EGFR-Mutant NSCLC May Benefit from Targeted Therapy More Than Checkpoint Inhibitors -...

Mar 26, 2024 - A recent retrospective, multicenter cohort study suggests osimertinib is more likely to benefit non-small cell lung cancer patients with EGFR mutations than...

targeted therapy patients egfr mutant nsclc